Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 19/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8926046 | 0.91 | CCKBR (0.54) | CCKBR | |
| SCHEMBL8919295 | 0.90 | CCKBR (0.48) | CCKBRMEN1NPC1LMNAEPHX1 | |
| SCHEMBL8922134 | 0.89 | CCKBR (0.58) | CCKBR | |
| SCHEMBL8922117 | 0.88 | CCKBR (0.48) | CCKBRMEN1NPC1LMNAEPHX1 | |
| SCHEMBL8921850 | 0.80 | CCKBR (0.46) | CCKBRNPC1EPHX2RAB9A | |
| SCHEMBL8922579 | 0.80 | CCKBR (0.54) | CCKBR | |
| SCHEMBL8920231 | 0.80 | CCKBR (0.31) | CCKBR | |
| SCHEMBL8919164 | 0.80 | CCKBR (0.48) | CCKBRNPC1EPHX2RAB9A | |
| SCHEMBL8924344 | 0.79 | CCKBR (0.48) | CCKBRMEN1NPC1LMNAEPHX2 | |
| SCHEMBL9362777 | 0.78 | CCKBR (0.49) | CCKBRMEN1NPC1LMNAEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5643904-A | Substituted hexahdryoazepinones and tetrahydrobenzazepinones | PFIZER INC. (US) | 1997-07-01 | — | — | US | disclosed |
| US-5484917-A | FOR TREATMENT AND PREVENTION OF GASTROINTESTINAL DISORDERS, PAIN AND ANXIETY | PFIZER INC. (US) | 1996-01-16 | — | — | US | disclosed |
| EP-0625145-A1 | 3-PHENYLUREIDO-AZEPIN-2-ONES AND -BENZAZEPIN-2-ONES USEFUL AS CHOLECYSTOKININ ANTAGONISTS | PFIZER INC. (US) | 1994-11-23 | — | — | EP | disclosed |
| WO-1993015059-A1 | 3-PHENYLUREIDO-AZEPIN-2-ONES AND -BENZAZEPIN-2-ONES USEFUL AS CHOLECYSTOKININ ANTAGONISTS | PFIZER INC. (US) | 1993-08-05 | — | — | WO | disclosed |